Subscribe to Newsletter

Pascal Soriot

The Power List 2016

Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

While at Roche, Soriot was in charge of integrating Genentech, the Californian biotech company, after a $47 billion takeover. He also led AstraZenica in a successful defense against acquisition by Pfizer in 2014 – a feat few envisaged before he took the reins. Soriot worked as a vet before embarking on his career in business.

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine